Literature DB >> 27088232

Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors.

Dong Guo1, Laura H Heitman1, Adriaan P IJzerman1.   

Abstract

Ligand-receptor binding kinetics is an emerging topic in the drug research community. Over the past years, medicinal chemistry approaches from a kinetic perspective have been increasingly applied to G protein-coupled receptors including the adenosine receptors (AR), which are involved in a plethora of physiological and pathological conditions. The study of ligand-AR binding kinetics offers room for detailed structure-kinetics relationships next to more traditional structure-activity relationships. Their combination may facilitate the triage of candidate compounds in hit-to-lead campaigns. Furthermore, kinetic studies also help in understanding AR allosterism. Allosteric modulation may yield a change in the activity and conformation of a receptor resulting from the binding of a compound at a site distinct from where the endogenous agonist adenosine binds. Hence, in this Review, we summarize available data and evidence for the binding kinetics of orthosteric and allosteric AR ligands. We hope this Review will raise awareness to consider the kinetic aspects of drug-target interactions on both ARs and other drug targets.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27088232     DOI: 10.1021/acs.chemrev.6b00025

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


  12 in total

1.  Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics.

Authors:  Giuseppe Deganutti; Andrei Zhukov; Francesca Deflorian; Stephanie Federico; Giampiero Spalluto; Robert M Cooke; Stefano Moro; Jonathan S Mason; Andrea Bortolato
Journal:  In Silico Pharmacol       Date:  2017-11-20

2.  A binding kinetics study of human adenosine A3 receptor agonists.

Authors:  Lizi Xia; Athina Kyrizaki; Dilip K Tosh; Tirsa T van Duijl; Jacomina Cornelia Roorda; Kenneth A Jacobson; Adriaan P IJzerman; Laura H Heitman
Journal:  Biochem Pharmacol       Date:  2018-01-03       Impact factor: 5.858

3.  The full activation mechanism of the adenosine A1 receptor revealed by GaMD and Su-GaMD simulations.

Authors:  Yang Li; Jixue Sun; Dongmei Li; Jianping Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

4.  Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists.

Authors:  Lizi Xia; Wessel A C Burger; Jacobus P D van Veldhoven; Boaz J Kuiper; Tirsa T van Duijl; Eelke B Lenselink; Ellen Paasman; Laura H Heitman; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2017-08-30       Impact factor: 7.446

5.  Supporting the Identification of Novel Fragment-Based Positive Allosteric Modulators Using a Supervised Molecular Dynamics Approach: A Retrospective Analysis Considering the Human A2A Adenosine Receptor as a Key Example.

Authors:  Giuseppe Deganutti; Stefano Moro
Journal:  Molecules       Date:  2017-05-16       Impact factor: 4.411

6.  Quantifying the Interactions between Biomolecules: Guidelines for Assay Design and Data Analysis.

Authors:  Peter J Tonge
Journal:  ACS Infect Dis       Date:  2019-04-13       Impact factor: 5.084

Review 7.  Gaussian accelerated molecular dynamics for elucidation of drug pathways.

Authors:  Apurba Bhattarai; Yinglong Miao
Journal:  Expert Opin Drug Discov       Date:  2018-10-29       Impact factor: 6.098

Review 8.  Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding.

Authors:  Antonella Ciancetta; Kenneth A Jacobson
Journal:  Molecules       Date:  2017-03-11       Impact factor: 4.411

9.  A two-state model for the kinetics of competitive radioligand binding.

Authors:  Dong Guo; Lambertus A Peletier; Lloyd Bridge; Wesley Keur; Henk de Vries; Annelien Zweemer; Laura H Heitman; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

Review 10.  Anti-apoptotic Actions of Allopregnanolone and Ganaxolone Mediated Through Membrane Progesterone Receptors (PAQRs) in Neuronal Cells.

Authors:  Peter Thomas; Yefei Pang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-24       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.